VKH
BPMC

Virtu KCG Holdings’s Blueprint Medicines BPMC Stock Holding History

Virtu KCG Holdings’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$457K Sell
9,017
-2,376
-21% -$101K 0.01% 1228
2017
Q1 		$456K Buy
+11,393
New +$408K 0.01% 1481
2015
Q4 		– Sell
-9,922
Closed -$212K – 3503
2015
Q3 		$212K Buy
+9,922
New +$274K ﹤0.01% 2507

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Virtu KCG Holdings's BPMC Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Blueprint Medicines (BPMC) stake by 21% in Q2 2017, selling an estimated $101K and leaving 9,017 shares worth $457K. The position accounts for 0.01% of the portfolio, ranked #1228.

Virtu KCG Holdings first reported a position in BPMC in Q3 2015 and has held it in 3 quarters since. 124 funds tracked by Wall St. Rank hold BPMC as of Q2 2017.

  • Virtu KCG Holdings held 9,017 shares of Blueprint Medicines worth $457K as of Q2 2017.
  • Virtu KCG Holdings sold 2,376 Blueprint Medicines shares in Q2 2017, an estimated $101K.
  • Blueprint Medicines made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1228 holding.
  • Virtu KCG Holdings first reported a position in Blueprint Medicines in Q3 2015 and has held it in 3 quarters since.
  • 124 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.